版本:
中国

BRIEF-Aclaris Therapeutics reports notice of allowance for 2 U.S. patent applications

April 4 Aclaris Therapeutics Inc:

* Aclaris Therapeutics announces notice of allowance for two U.S. Patent applications covering baricitnib and decernotinib, respectively, for hair loss disorders

* Aclaris Therapeutics Inc - newly allowed patent applications are owned by trustees of Columbia University in city of New York and exclusively licensed to co Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐